Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fresenius Medical Care Ag ADR (NY: FMS ) 19.39 +0.03 (+0.15%) Official Closing Price Updated: 4:10 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Fresenius Medical Care Ag ADR < Previous 1 2 3 Next > Current Analysis: Fresenius Medical Care (FMS) August 12, 2024 Fresenius Medical Care (FMS) is the largest dialysis company in the world. Over the past year, Fresenius's share price fell just over 30% from $26.09 to $18.14 as of Monday’s market close. Via Talk Markets Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 30, 2024 Via Benzinga Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session July 30, 2024 Via Benzinga Fresenius Medical Care: Q4 Earnings Insights February 20, 2024 Via Benzinga A Preview Of Fresenius Medical Care's Earnings February 19, 2024 Via Benzinga Stock Analysis: Fresenius Medical Care June 18, 2024 Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. Via Talk Markets Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway June 11, 2024 You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on. Via InvestorPlace Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers May 17, 2024 Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... Via Benzinga Current Analysis: Fresenius Medical Care May 15, 2024 Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Via Talk Markets Topics Supply Chain Exposures Supply Chain FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 07, 2024 Via Benzinga AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session May 07, 2024 Via Benzinga Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday April 22, 2024 Via Benzinga Why Are Dialysis Provider Stocks Trading Higher On Tuesday? March 05, 2024 Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks Via Benzinga Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Via Benzinga NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday March 05, 2024 U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News March 05, 2024 Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease. Via Investor's Business Daily Stock Market Whiplash February 24, 2024 We've also got a look at the international real estate market. Via The Motley Fool Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details February 20, 2024 Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024. Via Benzinga Fresenius Medical Care Hit By Major Data Breach: Half A Million Patients Potentially Affected December 06, 2023 Fresenius Medical Care (NYSE: FMS) said in a Via Benzinga Only Have $100? 3 No-Brainer Stocks to Buy Right Now November 28, 2023 The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks. Via InvestorPlace Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? October 27, 2023 Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. Via Investor's Business Daily Earnings Scheduled For February 20, 2024 February 20, 2024 Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. Via Benzinga Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review October 13, 2023 The major indexes stalled at key levels amid weak breadth. Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Intraday Session October 11, 2023 Via Benzinga Why Dialysis Stocks Plunged Today October 11, 2023 Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know. Via The Motley Fool Why Shares of Fresenius Medical Care Were Dropping on Wednesday October 11, 2023 Positive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius. Via The Motley Fool What's Going On With Kidney Dialysis Provider Stocks Today? October 11, 2023 DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel Via Benzinga Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session October 11, 2023 Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... Via Benzinga Ozempic Is Moving a Bunch of Stocks Wednesday Morning October 11, 2023 Find out who the winners and losers are. Via The Motley Fool < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.